Obesity Strongly Linked to COPD in Individuals Who Never Smoked, Study Reports
Chronic obstructive pulmonary disease (COPD) is much more common in obese individuals ages 50 and older who have never smoked, according to a ... Read more
Updates
-
-
Few COPD Patients Enroll in Pulmonary Rehabilitation, Despite Benefits, Study Shows
Very few patients with chronic obstructive pulmonary disease (COPD) start pulmonary rehabilitation after being hospitalized, despite its proven benefits and clinical guidelines recommending ... Read more -
Mucus Protects Lungs by Forming Layers, Preventing Worsening of Lung Diseases, Studies Reveal
Two new studies highlight the important role of mucus in cleaning and protecting the lungs, and how its accumulation and impaired clearance can contribute to ... Read more -
Royal Philips Launching Motivational and Awareness Campaign to Mark World COPD Day
Health technology company Royal Philips is launching a global initiative on World COPD Day Wednesday in hopes of raising awareness of chronic obstructive pulmonary disease (COPD) ... Read more -
FDA Approves Yupelri as New Treatment for Adults with COPD
Theravance Biopharma and Mylan announced that the U.S. Food and Drug Administration (FDA) approved their New Drug Application (NDA) for revefenacin (TD-4208) as a maintenance ... Read more
-
COPD Foundation Launches App to Help Providers, Patients
The COPD Foundation has launched an app called the COPD Pocket Consultant Guide (PCG), designed ... -
COPD Patients Begin to Receive Synairgen’s Therapy SNG001 for Flu, Colds in Phase 2 Trial
Treatment administration has started in the second part of a Phase 2 trial evaluating ... -
Analysis of Long-term Oxygen Use in Some COPD Patients Makes Researchers Question Its Benefits
Long-term oxygen therapy may not benefit patients with mild to moderate chronic obstructive pulmonary ... -
Long-term Benzodiazepine Use May Increase COPD Patients’ Suicide Risk, Study Suggests
Patients with chronic obstructive pulmonary disease (COPD) on long-term treatment with benzodiazepines are at ... -
FDA Approves New Label for Stiolto Respimat Showing Efficacy Against COPD Flare-ups
The U.S. Food and Drug Administration (FDA) approved a new label for Stiolto Respimat ... -
VA Researchers Working on 3D-Printed Artificial Lung for Patients with COPD, Other Pulmonary Diseases
A fully functional 3D-printed artificial lung may someday help people with serious pulmonary illnesses, ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients
News
The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill ... Read more